Rivalry and Private Jets: The 48-Hour Knight Rescue

Aug. 9 (Bloomberg) -- Stephanie Ruhle takes us inside Knight Capital CEO Tom Joyce's the rescue options and why he chose to go with a group of investors rather than the offer received from Citadel. She speaks on Bloomberg Television's "Market Makers." (Source: Bloomberg)

Pitts: EpiPen Controversy Is an Opportunity for the FDA
42:59 - Peter Pitts, former FDA associate commissioner, comments on Mylan EpiPen costs during an interview with Bloomberg's Scarlet Fu, Joe Weisenthal and Matt Miller on "What'd You Miss?" (Source: Bloomberg)
  • S&P 500 Winners and Losers for 08/25
  • Pitts: Carson Block's St. Jude Comments Are a Market Play
  • Deep Dive: Treasuries, Jobless Claims and Inflation